Total Payments
$659,837
2024 Payments
$110,445
Companies
7
Transactions
151
Medicare Patients
958
Medicare Billing
$76,142
Payment Breakdown by Category
Consulting$658,839 (99.8%)
Travel$587.93 (0.1%)
Other$239.81 (0.0%)
Food & Beverage$170.09 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $658,839 | 144 | 99.8% |
| Travel and Lodging | $587.93 | 4 | 0.1% |
| Honoraria | $239.81 | 1 | 0.0% |
| Food and Beverage | $170.09 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $589,314 | 126 | $0 (2024) |
| Blueprint Medicines Corporation | $39,718 | 11 | $0 (2024) |
| Emergent BioSolutions Inc. | $16,725 | 5 | $0 (2024) |
| Kala Pharmaceuticals, Inc. | $8,288 | 3 | $0 (2022) |
| Coherus Biosciences Inc. | $5,400 | 4 | $0 (2020) |
| Apellis Pharmaceuticals, Inc. | $239.81 | 1 | $0 (2022) |
| Alcon Vision LLC | $152.86 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $110,445 | 25 | GlaxoSmithKline, LLC. ($81,670) |
| 2023 | $80,704 | 19 | GlaxoSmithKline, LLC. ($60,137) |
| 2022 | $99,394 | 24 | GlaxoSmithKline, LLC. ($83,767) |
| 2021 | $147,218 | 40 | GlaxoSmithKline, LLC. ($147,218) |
| 2020 | $171,872 | 30 | GlaxoSmithKline, LLC. ($166,472) |
| 2019 | $43,803 | 9 | GlaxoSmithKline, LLC. ($43,650) |
| 2018 | $5,800 | 3 | GlaxoSmithKline, LLC. ($5,800) |
| 2017 | $600.00 | 1 | GlaxoSmithKline, LLC. ($600.00) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $12,600.00 | General |
| 12/17/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,725.00 | General |
| 12/03/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 11/21/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $8,925.00 | General |
| 10/22/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $5,600.00 | General |
| 10/03/2024 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $4,125.00 | General |
| 09/17/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $5,600.00 | General |
| 08/23/2024 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 08/05/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,240.00 | General |
| 07/25/2024 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $11,250.00 | General |
| 07/11/2024 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $4,487.50 | General |
| 07/01/2024 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $2,812.50 | General |
| 06/24/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| 06/04/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| 05/28/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,725.00 | General |
| 04/15/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $630.00 | General |
| 04/15/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 03/01/2024 | Blueprint Medicines Corporation | — | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| 02/12/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| 02/05/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $6,125.00 | General |
| 01/31/2024 | Emergent BioSolutions Inc. | — | Consulting Fee | Cash or cash equivalent | $2,275.00 | General |
| 01/22/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $10,150.00 | General |
| 01/22/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $8,925.00 | General |
| 01/22/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| 01/22/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $875.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 223 | 443 | $95,471 | $17,861 |
| 2022 | 5 | 218 | 473 | $99,202 | $18,806 |
| 2021 | 5 | 269 | 533 | $102,323 | $21,683 |
| 2020 | 5 | 248 | 429 | $84,513 | $17,792 |
Total Patients
958
Total Services
1,878
Medicare Billing
$76,142
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67028 | Injection of drug into eye | Facility | 2023 | 37 | 105 | $51,375 | $8,129 | 15.8% |
| 92134 | Imaging of retina | Facility | 2023 | 89 | 211 | $20,045 | $3,734 | 18.6% |
| 92014 | Established patient complete exam of visual system | Facility | 2023 | 38 | 46 | $9,798 | $2,414 | 24.6% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2023 | 38 | 60 | $8,940 | $2,110 | 23.6% |
| 92004 | New patient complete exam of visual system | Facility | 2023 | 21 | 21 | $5,313 | $1,474 | 27.7% |
| 67028 | Injection of drug into eye | Facility | 2022 | 33 | 112 | $51,786 | $8,581 | 16.6% |
| 92014 | Established patient complete exam of visual system | Facility | 2022 | 65 | 93 | $19,809 | $4,965 | 25.1% |
| 92134 | Imaging of retina | Facility | 2022 | 88 | 226 | $21,470 | $4,067 | 18.9% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2022 | 21 | 31 | $4,619 | $953.44 | 20.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Facility | 2022 | 11 | 11 | $1,518 | $239.82 | 15.8% |
| 67028 | Injection of drug into eye | Facility | 2021 | 39 | 113 | $46,443 | $8,886 | 19.1% |
| 92134 | Diagnostic imaging of retina | Facility | 2021 | 105 | 258 | $24,510 | $4,780 | 19.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Facility | 2021 | 56 | 74 | $15,762 | $4,017 | 25.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2021 | 45 | 64 | $9,536 | $2,352 | 24.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Facility | 2021 | 24 | 24 | $6,072 | $1,647 | 27.1% |
| 67028 | Injection of drug into eye | Facility | 2020 | 38 | 95 | $39,045 | $7,887 | 20.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Facility | 2020 | 59 | 73 | $15,549 | $3,411 | 21.9% |
| 92134 | Diagnostic imaging of retina | Facility | 2020 | 91 | 186 | $17,600 | $3,275 | 18.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2020 | 49 | 64 | $9,536 | $2,370 | 24.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Facility | 2020 | 11 | 11 | $2,783 | $849.22 | 30.5% |
About Dr. David Kleinman, MD
Dr. David Kleinman, MD is a Retina Specialist healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568457752.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kleinman, MD has received a total of $659,837 in payments from pharmaceutical and medical device companies, with $110,445 received in 2024. These payments were reported across 151 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($658,839).
As a Medicare-enrolled provider, Kleinman has provided services to 958 Medicare beneficiaries, totaling 1,878 services with total Medicare billing of $76,142. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Rochester, NY
- Active Since 09/14/2005
- Last Updated 07/05/2023
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1568457752
Products in Payments
- Constellation (Device) $152.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Retina Specialist Doctors in Rochester
Dr. Vikas Khetan, Md, MD
Retina Specialist — Payments: $3,210
Retina Specialist $3,210
Sana Idrees, Md, MD
Retina Specialist — Payments: $2,052
Retina Specialist $2,052
Rajeev Ramchandran, M.d, M.D
Retina Specialist — Payments: $34.95
Retina Specialist $34.95
Joseph Giacalone, Md, MD
Retina Specialist
Retina Specialist
Dr. Raja Narayanan, Md, MD
Retina Specialist
Retina Specialist